Please login to the form below

Not currently logged in
Email:
Password:

FDA conforms to Plan B ruling

The FDA has announced it will not appeal against a federal court's ruling to allow the morning-after pill, Plan B, to be marketed in the US to girls aged 17 and over

The US Food and Drug Administration (FDA) has announced it will not appeal against a federal court's ruling to allow the morning-after pill, Plan B, to be marketed in the US to girls aged 17 and over.

In March 2009, Judge Edward Korman ruled that the FDA decision had been made on political grounds and was not consistent with the scientific findings made in 2005 by the Centre for Drug Evaluation and Research. 

The FDA has since notified Duramed Research, the manufacturers of the emergency contraceptive, that upon submission and approval of an appropriate application, Plan B can be marketed for use by girls over 17 years old without a prescription.

Duramed Research is a subsidiary of Teva Pharmaceuticals.

23rd April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics